Ex Vivo Chemosensitivity Profiling of Acute Myeloid Leukemia and Its Correlation With Clinical Response and Outcome to Chemotherapy

We evaluated the predictive value of the ex-vivo PharmaFlow PM platform in measuring the pharmacological activity of drug combinations consisting of 20 different chemotherapy regimens (20 Tx) administered in 104 acute myeloid leukemia (AML) patients. The predicted sensitivities of alternative treatm...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yi Zhang, Min Ji, Jin-Yan Zhao, Hua-Feng Wang, Chong-Wu Wang, Wei Li, Jing-Jing Ye, Fei Lu, Li-Hui Lin, Yan-Ting Gao, Jie Jin, Li Li, Chun-Yan Ji, Joan Ballesteros, Hong-Hu Zhu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-01-01
coleção:	Frontiers in Oncology
Assuntos:	acute myeloid leukemia ex vivo drug sensitivity test chemosensitivity precision medicine complete remission
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2021.793773/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!